Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the Aseptic Process Simulation (APS) qualification of its sterile manufacturing facility and newly available fill/finish capacity.
Risk Adjusted Net Present Value: What is the current valuation of HilleVax’s HIL-214
The revenue for HIL-214 is expected to reach an annual total of $24 mn by 2039 in the US based off GlobalDatas Expiry Model. The